125 related articles for article (PubMed ID: 11518765)
1. Genetic heterogeneity in the apolipoprotein C-III promoter and effects of insulin.
Dallinga-Thie GM; Groenendijk M; Blom RN; De Bruin TW; De Kant E
J Lipid Res; 2001 Sep; 42(9):1450-6. PubMed ID: 11518765
[TBL] [Abstract][Full Text] [Related]
2. Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia.
Groenendijk M; Cantor RM; Blom NH; Rotter JI; de Bruin TW; Dallinga-Thie GM
J Lipid Res; 1999 Jun; 40(6):1036-44. PubMed ID: 10357835
[TBL] [Abstract][Full Text] [Related]
3. New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia.
Groenendijk M; Cantor RM; De Bruin TW; Dallinga-Thie GM
J Lipid Res; 2001 Feb; 42(2):188-94. PubMed ID: 11181747
[TBL] [Abstract][Full Text] [Related]
4. The apolipoprotein A-I/C-III/A-IV gene cluster: ApoC-III and ApoA-IV expression is regulated by two common enhancers.
Vergnes L; Taniguchi T; Omori K; Zakin MM; Ochoa A
Biochim Biophys Acta; 1997 Oct; 1348(3):299-310. PubMed ID: 9366246
[TBL] [Abstract][Full Text] [Related]
5. Two initiator-like elements are required for the combined activation of the human apolipoprotein C-III promoter by upstream stimulatory factor and hepatic nuclear factor-4.
Pastier D; Lacorte JM; Chambaz J; Cardot P; Ribeiro A
J Biol Chem; 2002 Apr; 277(17):15199-206. PubMed ID: 11839757
[TBL] [Abstract][Full Text] [Related]
6. Vitamin A is linked to the expression of the AI-CIII-AIV gene cluster in familial combined hyperlipidemia.
Ribalta J; Girona J; Vallvé JC; La Ville AE; Heras M; Masana L
J Lipid Res; 1999 Mar; 40(3):426-31. PubMed ID: 10064730
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels.
Chen M; Breslow JL; Li W; Leff T
J Lipid Res; 1994 Nov; 35(11):1918-24. PubMed ID: 7868970
[TBL] [Abstract][Full Text] [Related]
8. Distal apolipoprotein C-III regulatory elements F to J act as a general modular enhancer for proximal promoters that contain hormone response elements. Synergism between hepatic nuclear factor-4 molecules bound to the proximal promoter and distal enhancer sites.
Kardassis D; Tzameli I; Hadzopoulou-Cladaras M; Talianidis I; Zannis V
Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):222-32. PubMed ID: 9012660
[TBL] [Abstract][Full Text] [Related]
9. Gender related association between genetic variations of APOC-III gene and lipid and lipoprotein variables in northern France.
Dallongeville J; Meirhaeghe A; Cottel D; Fruchart JC; Amouyel P; Helbecque N
Atherosclerosis; 2000 May; 150(1):149-57. PubMed ID: 10781646
[TBL] [Abstract][Full Text] [Related]
10. A variation in the apolipoprotein C-III gene is associated with an increased number of circulating VLDL and IDL particles in familial combined hyperlipidemia.
Ribalta J; La Ville AE; Vallvé JC; Humphries S; Turner PR; Masana L
J Lipid Res; 1997 Jun; 38(6):1061-9. PubMed ID: 9215535
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of the apolipoprotein A-IV gene involves synergism between a proximal orphan receptor response element and a distant enhancer located in the upstream promoter region of the apolipoprotein C-III gene.
Ktistaki E; Lacorte JM; Katrakili N; Zannis VI; Talianidis I
Nucleic Acids Res; 1994 Nov; 22(22):4689-96. PubMed ID: 7984419
[TBL] [Abstract][Full Text] [Related]
12. A short proximal promoter and the distal hepatic control region-1 (HCR-1) contribute to the liver specificity of the human apolipoprotein C-II gene. Hepatic enhancement by HCR-1 requires two proximal hormone response elements which have different binding specificities for orphan receptors HNF-4, ARP-1, and EAR-2.
Vorgia P; Zannis VI; Kardassis D
J Biol Chem; 1998 Feb; 273(7):4188-96. PubMed ID: 9461615
[TBL] [Abstract][Full Text] [Related]
13. Two newly identified SNPs in the APO AI-CIII intergenic region are strongly associated with familial combined hyperlipidaemia.
Groenendijk M; Cantor RM; Funke H; Dallinga-Thie GM
Eur J Clin Invest; 2001 Oct; 31(10):852-9. PubMed ID: 11737222
[TBL] [Abstract][Full Text] [Related]
14. Synergism between nuclear receptors bound to specific hormone response elements of the hepatic control region-1 and the proximal apolipoprotein C-II promoter mediate apolipoprotein C-II gene regulation by bile acids and retinoids.
Kardassis D; Roussou A; Papakosta P; Boulias K; Talianidis I; Zannis VI
Biochem J; 2003 Jun; 372(Pt 2):291-304. PubMed ID: 12585964
[TBL] [Abstract][Full Text] [Related]
15. ApoC-III gene polymorphisms and risk of coronary artery disease.
Olivieri O; Stranieri C; Bassi A; Zaia B; Girelli D; Pizzolo F; Trabetti E; Cheng S; Grow MA; Pignatti PF; Corrocher R
J Lipid Res; 2002 Sep; 43(9):1450-7. PubMed ID: 12235176
[TBL] [Abstract][Full Text] [Related]
16. Characterization of an enhancer element in the human apolipoprotein C-III gene that regulates human apolipoprotein A-I gene expression in the intestinal epithelium.
Bisaha JG; Simon TC; Gordon JI; Breslow JL
J Biol Chem; 1995 Aug; 270(34):19979-88. PubMed ID: 7650015
[TBL] [Abstract][Full Text] [Related]
17. Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia.
Eichenbaum-Voline S; Olivier M; Jones EL; Naoumova RP; Jones B; Gau B; Patel HN; Seed M; Betteridge DJ; Galton DJ; Rubin EM; Scott J; Shoulders CC; Pennacchio LA
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):167-74. PubMed ID: 14551155
[TBL] [Abstract][Full Text] [Related]
18. Activation of CAAT enhancer-binding protein delta (C/EBPdelta) by interleukin-1 negatively influences apolipoprotein C-III expression.
Lacorte JM; Ktistaki E; Beigneux A; Zannis VI; Chambaz J; Talianidis I
J Biol Chem; 1997 Sep; 272(38):23578-84. PubMed ID: 9295296
[TBL] [Abstract][Full Text] [Related]
19. Foxo1 mediates insulin action on apoC-III and triglyceride metabolism.
Altomonte J; Cong L; Harbaran S; Richter A; Xu J; Meseck M; Dong HH
J Clin Invest; 2004 Nov; 114(10):1493-503. PubMed ID: 15546000
[TBL] [Abstract][Full Text] [Related]
20. Effect of apoC-III gene polymorphisms on the lipoprotein-lipid profile of viscerally obese men.
Couillard C; Vohl MC; Engert JC; Lemieux I; Houde A; Almeras N; Prud'homme D; Nadeau A; Despres JP; Bergeron J
J Lipid Res; 2003 May; 44(5):986-93. PubMed ID: 12588953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
